Omkar Pharmachem Ltd — Important, 16-02-2026: Company Update

Omkar Pharmachem has announced its financial results for the quarter and nine months ended December 31, 2025. For the quarter, total income from operations was Rs. 0.105 Cr, with a net profit after tax of Rs. 0.03 Cr, and Basic and Diluted EPS of Rs. 0.0293. Over the nine-month period, total income reached Rs. 0.379 Cr, generating a net profit after tax of Rs. 0.107 Cr, and Basic and Diluted EPS of Rs. 0.1059. These results inform investors about the company's financial performance during the respective periods.